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Abstract
Pseudohyperkalemia can appear in a variety of settings and should be recognized early. Treatment of pseudohy-
perkalemia can lead to an inappropriate decrease of actual serum potassium levels which may lead to life threaten-
ing conditions. In the case presented, an 81-year-old male presented with massive leucocytosis and an extremely
elevated potassium level. This case report emphasizes the importance of recognizing pseudohyperkalemia in a
patient with a severely increased potassium and WBC level; such patients may be clinically asymptomatic or may
have a normal ECG.
Case Presentation
An 81 year old Caucasian male presented to the emer-
gency department (ED) complaining of blurred vision.
One year ago he was diagnosed with Chronic Lympho-
cytic Leukemia (CLL) via lymph node biopsy and was
unfortunately lost to followup. Two days prior to his
presentation to the ED he was seen by an ophthalmolo-
gist for the same complaint. After a dilated eye examina-
tion the physician instructed him to go the ED after
discovering a retinal hemorrhage.
In the ED, the WBC measured 796,000 per cubic
millimeter and serum potassium was 7.5 mmol/L. Sub-
sequently, he was given intravenous calcium chloride,
dextrose 50%, insulin and kaaxylate. A 12 lead ECG did
not reveal any changes.
Repeat serum potassium was drawn after the initial
treatments revealing an increased measurement from to
9.8 mmol/L. A repeat ECG did not show any new
changes and the patient continued to be asymptomatic.
Verification to the lab was conducted to rule out hemo-
lysis or clotting.
Calcium chloride, dextrose 50%, and insulin were
repeated, and a higher dose of oral Kayexalate was
given. The patient was quickly admitted to the telemetry
unit for close monitoring. Potassium was again drawn in
order to verify that the potassium levels were decreas-
ing, however the serum potassium level continued to
increase. Repeat potassium 16 hours after the first
potassium values were reported was 11.8 mmol/L.
After extensive research of the literature it was identi-
fied that the extremely high leukocytosis was most prob-
ably the cause of the pseudohyperkalemia. Our research
prompted the use of a more immediate and mechani-
cally benign method utilizing a gas analyzer that
returned a potassium level of 2.4 mmol/L.
Discussion
Hyperkalemia is a life threatening electrolyte derangement
that must be quickly recognized and treated. Normal
serum potassium levels are between 3.5-5.0 mmol/L. Mild
hyperkalemia ranges from 5.1-6.1 mmol/L, moderate
between 6.2-7.0 mmol/L and severe above 7.0 mmol/L.
Cardiovascular and neurologic dysfunctions are the
primary manifestations of hyperkalemia. The most ser-
ious manifestation of hyperkalemia are due hyperexci-
teablilty of tissues. Patients may have a variety of
dysrhythmias, including second- and third-degree heart
block, wide-complex tachycardia, ventricular fibrillation,
and even asystole. Studies validate a good correlation
between the degree of hyperkalemia and ECG changes
[1]. The ECG can provide valuable clues to the presence
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of hyperkalemia of which peaked T waves are the first
characteristic manifestation. Further rises are associated
with progressive ECG changes, including loss of P
waves, and widening and slurring of the QRS complexes.
Eventually, the tracing assumes a sine wave appearance,
followed by ventricular fibrillation or asystole [2].
Neuromuscular signs and symptoms of hyperkalemia
include muscle cramps, weakness, paralysis, paresthesias,
tetany, and focal neurologic deficits [2]. Severe hyperka-
lemia should be promptly identified and treated as it
can quickly lead to death. The treatment of hyperkale-
mia is initiated by membrane stabilization with either
calcium gluconate or hypertonic sodium chloride, and
then by redistribution of potassium using short acting
insulin and dextrose, and/or Albuterol. Furthermore,
potassium may be elmininated in the body by use of
either loop diuretics or a resin binder such as, Kayexa-
late. emodialysis should be considered for elevated
potassium levels that are refractive to other treatments,
if available it is the most reliable and definitive method
in decreasing serum potassium levels [3].
As noted in the above case, a diagnosis of pseudohyper-
kalemia carries with it an absence of ECG changes consis-
tent with the serum potassium measurements. As
potassium levels attain 10 mmol/L, SA nodal conduction
no longer exists and passive junctional pacemakers emerge
producing an accelerated junctional rhythm. Widening of
the QRS complex and the T-wave with obliteration of the
ST-segment follows. The QRST is replaced by a smooth
diphasic sine wave. This finding is a pre-terminal event
unless treatment is initiated immediately [4]. The fatal
event is either asystole, as there is complete block in ven-
tricular conduction, or ventricular fibrillation.
There are a few hypotheses of the causes of falsely ele-
vated potassium levels in patients with extreme leukocy-
tosis. One theory is from 1975, prior to the routine use
heparinized tubes for collection sampling, postulating
that potassium is released from the white blood cells
during the clotting process [5]. As all of our samples
were collected into heparinized tubes and no clotting
was noted by the laboratory staff we will reject this the-
ory in our patient. A more recent case report postulated
that hyperkalemia may be caused by the combination of
the fragility of the leukemic lymphocytes and the
mechanical stress the vacuum tubes have on the cells as
the samples are collected causing release of intracellular
potassium into the serum[6]. Another likely explanation
of the pseudohyperkalemia is that severe leukocytosis
will have higher consumption of metabolic fuels that
may lead to impaired Na/K ATPase pump activity
which may contribute to release of potassium from the
high number of white cells [7].
Our conventional method of measuring serum potas-
sium level was not correct and in order to minimize the
time and mechanical stress of the sample collection we
used the Bayer Gas analyzer Assay from an arterial
blood gas syringe [7]. The sample collected with this
method showed a serum potassium level of 2.4 mmol/L.
Hypokalemia was quickly recognized and potassiumlow-
ering therapy was discontinued.
Conclusion
The exact mechanism of pseudohyperkalemia in
extreme leukocytosis is not clear., However, the pre-
sence of pseudohyperkalmia should be strongly sus-
pected with elevated potassium, the absence of clinical
signs of hyperkalemia, a normal ECG, and the presence
of extreme leukocytosis.
Consent
Written informed consent could not be obtained
because the patient was lost to follow-up. Despite
repeated attempts we were unable to trace the patient
or their family. Every effort has been made to keep the
patient’s identity anonymous. We would not expect the
patient or their family to object to publication.
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